TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended December 31 2023 along with the Limited Review Report issued by the Statutory Auditors of the Company. 2.To transact such other business as may be required.